← All trials
NCT06427239
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 29, 2024
- Primary completion
- Jun 30, 2026
- Completion date
- Sep 30, 2026
- First posted
- May 23, 2024
- Last posted
- Aug 9, 2024
- Enrollment
- 35
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Fudan UniversityLead sponsor
- Hengrui Therapeutics, Inc.Collaborator
- Fudan UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.